Healthpeak Properties (NYSE:DOC) Updates FY 2025 Earnings Guidance

Healthpeak Properties (NYSE:DOC - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 1.810-1.870 for the period, compared to the consensus EPS estimate of 1.94. The company issued revenue guidance of -.

Healthpeak Properties Price Performance

DOC stock traded down $0.31 on Monday, reaching $17.29. 13,633,942 shares of the company's stock were exchanged, compared to its average volume of 6,212,898. The stock has a fifty day moving average of $17.68 and a 200-day moving average of $18.81. Healthpeak Properties has a twelve month low of $16.64 and a twelve month high of $23.26. The firm has a market cap of $12.01 billion, a PE ratio of 72.04, a P/E/G ratio of 2.02 and a beta of 1.03. The company has a quick ratio of 1.35, a current ratio of 1.28 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%. The firm had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. During the same quarter in the prior year, the company posted $0.45 earnings per share. Healthpeak Properties's quarterly revenue was down .2% on a year-over-year basis. As a group, equities analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be issued a dividend of $0.1017 per share. This represents a $1.22 dividend on an annualized basis and a yield of 7.06%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's dividend payout ratio is presently 508.33%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Wells Fargo & Company dropped their price target on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. Evercore ISI dropped their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Scotiabank dropped their price target on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research report on Monday, May 12th. Argus restated a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Finally, Robert W. Baird dropped their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the company's stock. According to MarketBeat, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and a consensus price target of $23.27.

Insider Activity

In related news, CEO Scott M. Brinker purchased 2,750 shares of the firm's stock in a transaction on Friday, May 9th. The shares were bought at an average price of $17.39 per share, for a total transaction of $47,822.50. Following the acquisition, the chief executive officer directly owned 204,613 shares in the company, valued at $3,558,220.07. This trade represents a 1.36% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, Director Tommy G. Thompson purchased 5,777 shares of the firm's stock in a transaction on Wednesday, May 28th. The stock was bought at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the acquisition, the director owned 144,290 shares in the company, valued at $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 14,227 shares of company stock worth $246,543. Insiders own 0.23% of the company's stock.

Hedge Funds Weigh In On Healthpeak Properties

Large investors have recently modified their holdings of the company. Integrated Wealth Concepts LLC lifted its stake in shares of Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust's stock valued at $366,000 after purchasing an additional 1,231 shares in the last quarter. Woodline Partners LP lifted its stake in shares of Healthpeak Properties by 41.3% in the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust's stock valued at $1,195,000 after purchasing an additional 17,279 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Healthpeak Properties by 110.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust's stock valued at $2,463,000 after purchasing an additional 63,930 shares in the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.